scholarly article | Q13442814 |
P50 | author | Pablo Blinder | Q38328938 |
Feng Han | Q87811285 | ||
Ying-Mei Lu | Q92346075 | ||
P2093 | author name string | Huan Wang | |
Gang Wu | |||
Quan Jiang | |||
Sen Long | |||
Cheng-Kun Wang | |||
Dong-Mei Gong | |||
Ling-Juan Hong | |||
Yi-Xuan Yin | |||
P2860 | cites work | From molecules to neural morphology: understanding neuroinflammation in autism spectrum condition | Q26770325 |
Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate | Q26782938 | ||
Modeling psychiatric disorders for developing effective treatments | Q26784269 | ||
Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease | Q26822941 | ||
Inflammasomes: mechanism of action, role in disease, and therapeutics | Q27001186 | ||
PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrier | Q27303034 | ||
A computational perspective on autism | Q27320751 | ||
Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein | Q28264162 | ||
Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury | Q28286412 | ||
Infant siblings and the investigation of autism risk factors | Q28388355 | ||
AMPAKINE enhancement of social interaction in the BTBR mouse model of autism | Q28388762 | ||
The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi | Q28513807 | ||
Autism-like behavioral phenotypes in BTBR T+tf/J mice | Q29615512 | ||
Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010 | Q29615713 | ||
Two-photon microscopy as a tool to study blood flow and neurovascular coupling in the rodent brain | Q30452927 | ||
National autism prevalence trends from United States special education data | Q30983930 | ||
Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. | Q33685348 | ||
Adhesion molecule expression and regulation on cells of the central nervous system | Q33701566 | ||
Nitrosative stress induces peroxiredoxin 1 ubiquitination during ischemic insult via E6AP activation in endothelial cells both in vitro and in vivo | Q33722929 | ||
Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders | Q33925249 | ||
In vivo two-photon fluorescence microscopy reveals disturbed cerebral capillary blood flow and increased susceptibility to ischemic insults in diabetic mice | Q34066952 | ||
A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures | Q34238394 | ||
Levels of soluble platelet endothelial cell adhesion molecule-1 and P-selectin are decreased in children with autism spectrum disorder | Q34282952 | ||
Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome | Q34348399 | ||
Cathepsin B regulates the appearance and severity of mercury-induced inflammation and autoimmunity | Q34605988 | ||
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. | Q35350543 | ||
Adhesion molecules and atherosclerosis | Q35581561 | ||
P2RX7 sensitizes Mac-1/ICAM-1-dependent leukocyte-endothelial adhesion and promotes neurovascular injury during septic encephalopathy | Q35638779 | ||
Chemokines: multiple levels of leukocyte migration control. | Q35753105 | ||
Neuro-inflammation, blood-brain barrier, seizures and autism | Q35800334 | ||
Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions | Q35887816 | ||
MET is required for the recruitment of anti-tumoural neutrophils | Q36125652 | ||
Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain | Q36135928 | ||
Large brains in autism: the challenge of pervasive abnormality | Q36252809 | ||
Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, six sites, United States, 2000. | Q36731062 | ||
Getting leukocytes to the site of inflammation | Q36772662 | ||
Interleukin-1beta and caspase-1: players in the regulation of age-related cognitive dysfunction | Q36861439 | ||
Autism spectrum disorder: advances in evidence-based practice | Q37702247 | ||
Microglia in neurodegenerative disease | Q37710380 | ||
Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults | Q37984014 | ||
Potential cytokine biomarkers in autism spectrum disorders | Q38268751 | ||
The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders | Q38485016 | ||
Immune mediators in the brain and peripheral tissues in autism spectrum disorder | Q38550206 | ||
Immune Alterations in CD8(+) T Cells Are Associated with Neuronal C-C and C-X-C Chemokine Receptor Regulation Through Adenosine A2A Receptor Signaling in a BTBR T(+) Itpr3(tf)/J Autistic Mouse Model. | Q38728524 | ||
Cathepsin B and L inhibitors: a patent review (2010 - present). | Q39044784 | ||
ICAM-1 clustering on endothelial cells recruits VCAM-1 | Q39668039 | ||
Severe impairments of social interaction and associated abnormalities in children: Epidemiology and classification | Q39883042 | ||
Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6. | Q41270272 | ||
Serum levels of soluble platelet endothelial cell adhesion molecule-1 and vascular cell adhesion molecule-1 are decreased in subjects with autism spectrum disorder. | Q41501738 | ||
Effects of cathepsins B and L inhibition on postischemic protein alterations in the brain | Q41845961 | ||
NLRs and the dangers of pollution and aging | Q42554239 | ||
Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation | Q42736872 | ||
Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid | Q46398714 | ||
Altered plasma levels of chemokines in autism and their association with social behaviors | Q47406645 | ||
High expression of Endogenous Retroviruses from intrauterine life to adulthood in two mouse models of Autism Spectrum Disorders | Q47556317 | ||
Melatonin reverses the decreases in hippocampal protein serine/threonine kinases observed in an animal model of autism | Q47763262 | ||
Elevated levels of tissue plasminogen activator and E-selectin in male children with autism spectrum disorder. | Q50210143 | ||
Decreased serum levels of platelet-endothelial adhesion molecule (PECAM-1) in subjects with high-functioning autism: a negative correlation with head circumference at birth. | Q50313597 | ||
Brain cytokines and neuropsychiatric disorders. | Q51935715 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | autism | Q38404 |
P304 | page(s) | 476-485 | |
P577 | publication date | 2018-10-16 | |
P1433 | published in | CNS Neuroscience & Therapeutics | Q5013184 |
P1476 | title | Cathepsin B inhibition ameliorates leukocyte-endothelial adhesion in the BTBR mouse model of autism | |
P478 | volume | 25 |
Q98465071 | The Role of Cathepsins in Memory Functions and the Pathophysiology of Psychiatric Disorders | cites work | P2860 |
Search more.